FIELD: medicine. SUBSTANCE: method involves filling tympanic cavity with beta-leukine at 10 ng/ml concentration after preparing the tympanic cavity. Exposure time is 10-15 min. Beta- leukine concentration is increased in the following days by 10 ng/ml daily not exceeding the 40 ng/ml limit. The treatment course is 4-6 days long. EFFECT: long-term stable remission.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PATIENT REHABILITATION AFTER TYMPANOPLASTY | 2007 |
|
RU2355416C2 |
| METHOD TO TREAT TONSILLITIS | 1997 |
|
RU2110301C1 |
| METHOD FOR IMPROVING AUDITORY FUNCTION IN THE CASES OF TYMPANOSCLEROSIS | 2002 |
|
RU2223084C1 |
| METHOD OF REVEALING NEUROSENSOR HEARING DISORDER AND ITS GROUP OF RISK | 1995 |
|
RU2084898C1 |
| METHOD OF TYMPANOPLASTY | 1999 |
|
RU2143934C1 |
| METHOD FOR TREATING INFLAMMATORY DISEASES OF UPPER RESPIRATORY TRACTS | 1995 |
|
RU2085180C1 |
| METHOD FOR TREATING RHINOSINUSITIS AND DEVICE FOR ITS IMPLEMENTATION | 2001 |
|
RU2187342C1 |
| SURGICAL METHOD FOR CLOSING FISTULA HORIZONTAL SEMICIRCULAR DUCT IN CIRCUMSCRIBED LABYRINTHITIS CASES | 2004 |
|
RU2277400C1 |
| METHOD FOR TREATING PARATONSILLAR ABSCESS | 2001 |
|
RU2187258C1 |
| METHOD OF TREATMENT OF PATIENTS WITH CHRONIC TONSILLITIS | 2000 |
|
RU2163130C1 |
